We propose to mesh the efforts of capable basic biologists exploring the mechanisms and markers of gastrointestinal epithelium transformation and differentiation with established clinical investigators attempting to define the diagnostic and therapeutic utility of conventional and new colorectal cancer phenotypes. This program will have the following goals: (1) improvement in the clinical utility of CEA and CEA-like markers by better definition of the metabolism and pharmacokinetics of shed glycoprotein; (2) definition of the biologic function of specific cell surface glycoproteins associated with colon and rectum cancers; (3) detailed biochemical analysis of the cell surface and cytoskeletal structures of colorectal cancer cells to determine molecular analogies between GI epithelial differentiation and transformation; (4) determination of relationships between phenotypes defined among colorectal cancers and gene products of oncogenes and proto-oncogenes known to be associated with human colorectal cancer and selected GI tumor model systems; (5) identification of new colorectal cancer cytoskeletal and cell surface phenotypes to define more useful markers of predominantly poorly differentiated gastrointestinal cancers; (6) application of new markers in clinical protocols to demonstrate in vivo targeting, serodiagnostic efficacy, and to monitor therapy. The themes that have consolidated these individual basic and clinical investigations are: (1) continuity with past accomplishments by Norman Zamcheck et al in defining the clinical utility of gastrointestinal tumor markers; (2) basic research and clinical interest in defining the mechanisms of synthesis, regulation, metabolism, and function of prototype and newly identified glycosylated GI tumor antigens; (3) a postulated relationship between GI epithelium differentiation and transformation phenotypes/genotypes; (4) an attempt to define a library of new GI epithelial differentiation markers by linkage to conventional morphologic categories of colon and rectum cancer differentiation and subsequent testing as differentiation markers applicable to normal GI epithelial maturation; and, most important (5) the establishment of efficient methods of transition from the basic biologic studies to appropriate clinical research protocols defining diagnostic and therapeutic utility of new markers in patients with colorectal cancer. Clinical progress in this disease will depend upon the kind of meshing of basic biologists and clinical researchers that this program project represents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA044704-01
Application #
3094143
Study Section
Cancer Therapeutics Program Project Review Committee (CTR)
Project Start
1987-06-01
Project End
1990-05-31
Budget Start
1987-06-01
Budget End
1988-05-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Lee, Y J; Galoforo, S S; Battle, P et al. (2001) Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy. Cancer Gene Ther 8:397-404
Lotz, M M; Rabinovitz, I; Mercurio, A M (2000) Intestinal restitution: progression of actin cytoskeleton rearrangements and integrin function in a model of epithelial wound healing. Am J Pathol 156:985-96
Bachelder, R E; Marchetti, A; Falcioni, R et al. (1999) Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J Biol Chem 274:20733-7
Jessup, J M; Ishii, S; Mitzoi, T et al. (1999) Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. Clin Exp Metastasis 17:481-8
Jessup, J M; Battle, P; Waller, H et al. (1999) Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res 59:1825-9
Rabinovitz, I; Toker, A; Mercurio, A M (1999) Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J Cell Biol 146:1147-60
Walsh, S; Murphy, M; Silverman, M et al. (1999) p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis. Am J Pathol 155:1511-8
Pories, S E; Hess, D T; Swenson, K et al. (1998) Overexpression of pp60c-src elicits invasive behavior in rat colon epithelial cells. Gastroenterology 114:1287-95
Jessup, J M (1998) Tumor markers--prognostic and therapeutic implications for colorectal carcinoma. Surg Oncol 7:139-51
Jessup, J M; Loda, M (1998) Prognostic markers in rectal carcinoma. Semin Surg Oncol 15:131-40

Showing the most recent 10 out of 143 publications